How Much Will COVID Boosters for Teens Impact Pfizer and BioNTech?

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) received expanded U.S. Emergency Use Authorization (EUA) of booster doses of their COVID-19 vaccine to teens ages 16 and 17 last week. In this Motley Fool Live video recorded on Dec. 1, Motley Fool contributors Keith Speights and Brian Orelli discuss how much potential authorization of boosters for this age group could impact the two companies.

Continue reading

Source Fool.com